Tech Council of Maryland Names GlycoMimetics, Inc. CEO Rachel King as 2013 Executive of the Year
5/17/2013 9:50:05 AM
More...
|
GlycoMimetics, Inc. Completes Enrollment in Phase 2 Sickle Cell Disease Study With Lead Drug Candidate GMI-1070
1/17/2013 9:22:19 AM
More...
|
GlycoMimetics, Inc. Announces Progress from Its Novel Compounds as Presented at 2012 American Society of Hematology Annual Meeting
12/11/2012 10:23:33 AM
More...
|
GlycoMimetics, Inc. Announces Publication in Nature Medicine of Preclinical Data for Its GMI-1070 Drug Candidate
10/22/2012 9:43:08 AM
More...
|
GlycoMimetics, Inc. Announces Presentation at National Sickle Cell Conference
9/24/2012 10:02:10 AM
More...
|
William E. Proudford Sickle Cell Fund Honors GlycoMimetics, Inc. With “Unsung Hero” Award
9/21/2012 10:08:09 AM
More...
|
International AIDS Vaccine Initiative, GlycoMimetics, Inc., and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate
5/9/2012 10:31:56 AM
More...
|
Tech Council of Maryland Names GlycoMimetics, Inc. as 2012 Life Sciences Company of the Year
4/27/2012 10:00:18 AM
More...
|
GlycoMimetics, Inc. Announces Two Key Leadership Promotions
1/5/2012 7:25:47 AM
More...
|
The Market Publishers, Ltd. Release: Generic Drug Companies Discussed in New Research Report Recently Published at MarketPublishers.com
12/13/2011 8:45:22 AM
More...
|
|